The success of NIPRO’s biosimilar product, launched in late 2023, has exceeded expectations and gained significant market ...

Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...

Will significantly enhance service to researchers and institutions across China.

Sanofi and Johnson & Johnson’s E. coli vaccine candidate failed to prevent invasive E. coli disease effectively.

AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, is expanding the scope and ...

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to CUSP06, a Cadherin-6 targeting ...

Alcami Corporation, a contract development and manufacturing organization (CDMO), has appointed pharmaceutical industry ...

The project is set to become the largest GMP temperature-controlled facility fully dedicated to the life sciences sector in ...

Novartis has agreed to acquire Anthos Therapeutics, Inc., a Boston-based, privately held, clinical-stage biopharmaceutical ...

PHC Corporation and CCRM have signed a Master Collaboration Agreement to collaborate on developing primary T-cell expansion ...

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery ...